On 4 December, the MULTIR  project participated in the EU Cancer Mission Conference  in Copenhagen, held under the framework of the EU Mission on Cancer. The project was represented by Prof. Harald Mischak (MOS) , who presented MULTIR’s work and its contribution to tackling the clinical challenge of variable patient responses to immunotherapy. His presentation emphasized the critical role of understanding tumour-host immune interactions in influencing treatment outcomes. The

On 2–3 October 2025, the MULTIR consortium held its 2nd Annual Meeting in Hannover, Germany. The event was kindly hosted by project partner MOS and ran in a hybrid format, with participants joining both on site and online from across Europe. A warm welcome in Hannover The meeting opened with a welcome from Prof. Lise Boussemart (INSERM–NUH), who thanked MOS for their hospitality and smooth organisation. She introduced the agenda for the two days, which combined project-wide u

The MULTIR consortium’s hybrid symposium brought together clinicians, researchers, AI experts, industry partners, ethicists and patient advocates from across Europe and beyond to explore how artificial intelligence can transform cancer care: safely, equitably and with patients at the centre. Anchored by opening remarks from Dr. Isabelle Budin Ljøsne  (Norwegian Institute of Public Health) and Prof. Lars Dyrskjøt Andersen  (Aarhus University), the programme focused on three